Login / Signup

The epidemiology of Stenotrophomonas maltophilia and Achromobacter xylosoxidans infections.

Shani Zilberman-ItskovichEdward CohenLeonid-Arie PloshanskyAlexander YusupovRuth BouganimKatie H JaffeDror Marchaim
Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2024)
Stenotrophomonas maltophilia and Achromobacter xylosoxidans are emerging nosocomial, non-glucose fermenting, Gram-negative pathogens. In this nested case-control trial, independent predictors for S. maltophilia infections were hemodialysis and recent antibiotic usage (overall), while recent usage of fluoroquinolones, was independently associated with A. xylosoxidans infections. Infections were independently associated with multiple worse outcomes.
Keyphrases